BlackRock Institutional Trust’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.83M Buy
18,812
+649
+4% +$155K ﹤0.01% 2820
2016
Q3
$6.32M Buy
18,163
+2,126
+13% +$562K ﹤0.01% 2597
2016
Q2
$3.33M Sell
16,037
-22
-0.1% -$4.85K ﹤0.01% 2850
2016
Q1
$4.32M Sell
16,059
-116
-0.7% -$31K ﹤0.01% 2738
2015
Q4
$6.79M Buy
16,175
+363
+2% +$162K ﹤0.01% 2558
2015
Q3
$7.2M Buy
15,812
+2,161
+16% +$956K ﹤0.01% 2504
2015
Q2
$6.88M Sell
13,651
-646
-5% -$296K ﹤0.01% 2611
2015
Q1
$7.21M Buy
14,297
+7,676
+116% +$4.68M ﹤0.01% 2584
2014
Q4
$3.97M Buy
6,621
+2,566
+63% +$1.03M ﹤0.01% 2818
2014
Q3
$1.26M Sell
4,055
-45
-1% -$16.2K ﹤0.01% 3245
2014
Q2
$1.61M Buy
4,100
+3,832
+1,430% +$1.58M ﹤0.01% 3281
2014
Q1
$148K Buy
+268
New +$183K ﹤0.01% 3735

Other funds holding ACGN

BlackRock Institutional Trust's ACGN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Aceragen Inc (ACGN) stake by 3.6% in Q4 2016, buying an estimated $155K and bringing the position to 18,812 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

BlackRock Institutional Trust first reported a position in ACGN in Q1 2014 and has held it in 12 quarters since. The position peaked at $7.21M in Q1 2015. 83 funds tracked by Wall St. Rank hold ACGN as of Q4 2016.

  • BlackRock Institutional Trust held 18,812 shares of Aceragen Inc worth $3.83M as of Q4 2016.
  • BlackRock Institutional Trust bought 649 Aceragen Inc shares in Q4 2016, an estimated $155K.
  • Aceragen Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2820 holding.
  • BlackRock Institutional Trust first reported a position in Aceragen Inc in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Institutional Trust's Aceragen Inc position peaked at $7.21M in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.